Press-release for stocks for novo nordisk a/s

entities : Novo nordisk a::S crawled time : 16:00

save search

Awiqli® (once-weekly basal insulin icodec) recommended for approval for the treatment of diabetes by the European regulatory authorities
Published: 2024-03-21 (Crawled : 16:00) - globenewswire.com
NVO | News | $125.26 2.08% 0.18% 3.6M

Health Technology

| -3.91% | O: -1.04% H: 1.6% C: 0.64%
awiqli approval treatment diabetes insulin

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2024-01-09 (Crawled : 16:00) - globenewswire.com
NVO | News | $125.26 2.08% 0.18% 3.6M

Health Technology

| 17.73% | O: -0.25% H: 0.79% C: 0.77%

Novo Nordisk invests more than 16 billion Danish kroner in expansion of production facilities in Chartres, France
Published: 2023-11-23 (Crawled : 16:00) - globenewswire.com
NVO | News | $125.26 2.08% 0.18% 3.6M

Health Technology

| Email alert Add to watchlist
expansion

Oral semaglutide 25 mg and 50 mg demonstrate superior reductions in HbA1c and body weight versus 14 mg in people with type 2 diabetes in the PIONEER PLUS phase 3 trial
Published: 2023-03-24 (Crawled : 16:00) - globenewswire.com
NVO | News | $125.26 2.08% 0.18% 3.6M

Health Technology

| -16.26% | O: 0.26% H: 2.45% C: 1.85%
trial diabetes plus

Novo Nordisk A/S - share repurchase programme
Published: 2023-03-13 (Crawled : 16:00) - globenewswire.com
NVO | News | $125.26 2.08% 0.18% 3.6M

Health Technology

| -11.35% | O: -0.02% H: 1.44% C: -0.51%
repurchase

Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2023-02-03 (Crawled : 16:00) - globenewswire.com
NVO | News | $125.26 2.08% 0.18% 3.6M

Health Technology

| -5.35% | O: 2.58% H: 1.24% C: 0.77%

Novo Nordisk A/S – Share repurchase programme
Published: 2022-12-12 (Crawled : 16:00) - globenewswire.com
NVO | News | $125.26 2.08% 0.18% 3.6M

Health Technology

| -2.83% | O: 0.49% H: 0.31% C: 0.21%
repurchase

Novo Nordisk A/S – Share repurchase programme
Published: 2022-11-21 (Crawled : 16:00) - globenewswire.com
NVO | News | $125.26 2.08% 0.18% 3.6M

Health Technology

| 10.42% | O: -0.19% H: 0.77% C: 0.17%
repurchase

Novo Nordisk A/S – Share repurchase programme
Published: 2022-11-14 (Crawled : 16:00) - globenewswire.com
NVO | News | $125.26 2.08% 0.18% 3.6M

Health Technology

| 12.37% | O: 3.13% H: 0.56% C: -0.46%
repurchase

Global Insulin Delivery Devices Market Report 2022-2030: Growing Diabetic Population & Surge in the Launch of Insulin Delivery Devices
Published: 2022-10-17 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| 14.71% | O: 0.67% H: 0.0% C: 0.0%
NVO | News | $125.26 2.08% 0.18% 3.6M

Health Technology

| 20.67% | O: 1.18% H: 1.26% C: 0.93%
MDT | $80.57 1.37% 0.0% 5M

Health Technology

| -1.27% | O: 1.46% H: 0.94% C: -0.05%
LLY | News | $731.33 0.69% 0.0% 2.3M

Health Technology

| 120.69% | O: 0.42% H: 1.44% C: -0.01%
BDX | $233.88 -0.1% 0.0% 770K

Health Technology

| 4.09% | O: 0.74% H: 1.69% C: 1.18%
SNY | News | $47.125 1.78% 1.75% 2.1M

Health Technology

| 15.76% | O: 0.51% H: 0.95% C: 0.65%
PODD | $164.46 -1.08% -1.09% 680K

Health Technology

| -25.64% | O: -0.52% H: 4.35% C: 1.9%
global report growing insulin market diabetic

Insights on the Next Generation Diabetes Therapy and Drug Delivery Global Market to 2030 - Rising Incidences of Diabetes Globally and Increase in the Disposable Income is Driving Growth
Published: 2022-09-30 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| 21.57% | O: -0.12% H: 0.0% C: 0.0%
NVO | News | $125.26 2.08% 0.18% 3.6M

Health Technology

| 24.77% | O: -0.19% H: 0.52% C: -0.57%
MDT | $80.57 1.37% 0.0% 5M

Health Technology

| -2.07% | O: 0.4% H: 1.14% C: -2.24%
JNJ | News | $149.12 0.82% 0.0% 9.3M

Health Technology

| -9.37% | O: 0.46% H: 0.0% C: 0.0%
LLY | News | $731.33 0.69% 0.0% 2.3M

Health Technology

| 121.61% | O: -0.87% H: 0.72% C: -1.16%
ABT | News | $107.07 -0.2% 0.0% 4.9M

Health Technology

| 8.93% | O: 0.43% H: 0.8% C: -1.98%
SNY | News | $47.125 1.78% 1.75% 2.1M

Health Technology

| 22.62% | O: 1.71% H: 0.0% C: 0.0%
MNKD | $4.12 -1.44% -1.46% 1.8M

Health Technology

| 37.46% | O: 0.33% H: 7.33% C: 3.0%
DXCM | $131.5 0.6% 0.6% 2.1M

Health Technology

| 60.19% | O: -0.38% H: 2.68% C: -1.53%
SENS | $0.3988 -0.1% 0.0% 2.2M

Electronic Technology

| -71.83% | O: -0.7% H: 2.84% C: -6.38%
drug global diabetes therapy growth market

Global Bleeding Disorders Treatment Market Report 2022: Healthy Growth Expected Driven By Key Players Bayer, Pfizer, Octapharma & Others
Published: 2022-09-16 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| 16.59% | O: 0.74% H: 0.91% C: -0.74%
NVO | News | $125.26 2.08% 0.18% 3.6M

Health Technology

| 21.36% | O: -1.76% H: 0.55% C: 0.03%
NVS | News | $95.12 0.81% -1.18% 2.4M

Health Technology

| 17.38% | O: 0.1% H: 0.25% C: -0.21%
LLY | News | $731.33 0.69% 0.0% 2.3M

Health Technology

| 136.32% | O: -0.48% H: 1.3% C: 0.3%
BAX | $40.4 2.36% 0.0% 3.2M

Health Technology

| -31.49% | O: -0.41% H: 0.16% C: -0.94%
SNY | News | $47.125 1.78% 1.75% 2.1M

Health Technology

| 13.78% | O: -0.52% H: 0.0% C: 0.0%
AMGN | News | $271.98 1.13% 1.12% 2.1M

Health Technology

| 19.44% | O: -0.34% H: 2.35% C: 1.87%
treatment bleeding global report expected growth market

Liver Fibrosis Market to Surge at a CAGR of 15.9% by 2032 | DelveInsight
Published: 2022-09-05 (Crawled : 16:00) - prnewswire.com
SGMT | News | $4.02 0.25% 0.25% 300K

Health Technology

| Email alert Add to watchlist
ETNB | $9.31 2.53% 2.47% 580K

Health Technology

| Email alert Add to watchlist
MDGL | $213.85 0.85% 0.85% 720K

Health Technology

| Email alert Add to watchlist
LPCN | $5.16 -2.09% -2.13% 21K

Health Technology

| Email alert Add to watchlist
NVO | News | $125.26 2.08% 0.18% 3.6M

Health Technology

| Email alert Add to watchlist
GALT | $3.055 -9.35% -10.31% 310K

Health Technology

| Email alert Add to watchlist
fibrosis liver market

Insulin Market to Exceed US$ 30 Bn by 2031; Global Burden of Diabetes and Complications Propelling Adoption of Therapies, Observes TMR Report
Published: 2022-06-20 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| Email alert Add to watchlist
SNY | News | $47.125 1.78% 1.75% 2.1M

Health Technology

| Email alert Add to watchlist
BDX | $233.88 -0.1% 0.0% 770K

Health Technology

| Email alert Add to watchlist
NVO | News | $125.26 2.08% 0.18% 3.6M

Health Technology

| Email alert Add to watchlist
LLY | News | $731.33 0.69% 0.0% 2.3M

Health Technology

| Email alert Add to watchlist
report diabetes insulin market

Novo Nordisk A/S:
Published: 2022-05-06 (Crawled : 16:00) - globenewswire.com
NVO | News | $125.26 2.08% 0.18% 3.6M

Health Technology

| 11.0% | O: -1.88% H: 1.63% C: 0.56%
BLK | $760.11 1.35% 0.0% 590K

Finance

| 19.93% | O: -0.4% H: 0.92% C: -0.42%

Novo Nordisk – major shareholder announcement
Published: 2022-03-04 (Crawled : 16:00) - globenewswire.com
NVO | News | $125.26 2.08% 0.18% 3.6M

Health Technology

| 20.13% | O: -2.23% H: 0.0% C: 0.0%
BLK | $760.11 1.35% 0.0% 590K

Finance

| 1.61% | O: -3.09% H: 0.0% C: 0.0%
announcement

Trading in Novo Nordisk shares by board members, executives and associated persons on 8 February 2022
Published: 2022-02-11 (Crawled : 16:00) - globenewswire.com
NVO | News | $125.26 2.08% 0.18% 3.6M

Health Technology

| 20.37% | O: -2.29% H: 0.0% C: 0.0%

Novo Nordisk A/S – Share repurchase programme
Published: 2022-02-07 (Crawled : 16:00) - globenewswire.com
NVO | News | $125.26 2.08% 0.18% 3.6M

Health Technology

| 23.31% | O: -0.8% H: 1.98% C: 0.98%
program

Novo Nordisk Brokers Another Deal in Fight Against Obesity
Published: 2022-01-17 (Crawled : 16:00) - biospace.com/
NVO | News | $125.26 2.08% 0.18% 3.6M

Health Technology

| Email alert Add to watchlist
obesity deal